Literature DB >> 24043735

Targeting the RANKL pathway: putting the brakes on prostate cancer progression in bone.

Isla P Garraway1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24043735     DOI： 10.1200/JCO.2013.50.1544

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Metastasis initiating cells in primary prostate cancer tissues from transurethral resection of the prostate (TURP) predicts castration-resistant progression and survival of prostate cancer patients.

Authors:  Qinlong Li; Quanlin Li; Jill Nuccio; Chunyan Liu; Peng Duan; Ruoxiang Wang; Lawrence W Jones; Leland W K Chung; Haiyen E Zhau
Journal:  Prostate       Date:  2015-05-19       Impact factor: 4.104

2.  Impact of denosumab use on the survival of untreated non-squamous non-small cell lung cancer patients with bone metastases.

Authors:  Hibiki Udagawa; Seiji Niho; Keisuke Kirita; Shigeki Umemura; Shingo Matsumoto; Kiyotaka Yoh; Koichi Goto
Journal:  J Cancer Res Clin Oncol       Date:  2017-02-20       Impact factor: 4.553

3.  The Effects of TGF-β Signaling on Cancer Cells and Cancer Stem Cells in the Bone Microenvironment.

Authors:  Mitsuru Futakuchi; Kris Lami; Yuri Tachibana; Yukari Yamamoto; Masahiro Furukawa; Junya Fukuoka
Journal:  Int J Mol Sci       Date:  2019-10-15       Impact factor: 5.923

4.  Therapeutic and Preventive Effects of Osteoclastogenesis Inhibitory Factor on Osteolysis, Proliferation of Mammary Tumor Cell and Induction of Cancer Stem Cells in the Bone Microenvironment.

Authors:  Mitsuru Futakuchi; Takao Nitanda; Saeko Ando; Harutoshi Matsumoto; Eri Yoshimoto; Katsumi Fukamachi; Masumi Suzui
Journal:  Int J Mol Sci       Date:  2018-03-16       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.